| Company Name: |
Nanjing Peptide Biotech Ltd.
|
| Tel: |
025-025-58361106-805-805 13082558573 |
| Email: |
liugang@njpeptide.com |
| Products Intro: |
Product Name:Trebananib
CAS:894356-79-7
Purity:90%HPLC,95%HPLC,98%HPLC Package:5mg,20mg,100mg,250mg,500mg,1g
|
| Company Name: |
Wuhan Chemstan Biotechnology Co., Ltd.
|
| Tel: |
027-65317797 15926423062 |
| Email: |
422450190@qq.com |
| Products Intro: |
Product Name:Research Grade Trebananib
CAS:894356-79-7
Purity:>95%;1mg/ml Package:100ug;1mg;20mg
|
| Company Name: |
Atagenix Laboratories
|
| Tel: |
027-87008169 17762441161 |
| Email: |
info@atagenix.com |
| Products Intro: |
Product Name:Research Grade Trebananib
CAS:894356-79-7
Purity:>95% Package:100ug
|
|
| | AMG-386,Trebananib Basic information |
| | AMG-386,Trebananib Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | AMG-386,Trebananib Usage And Synthesis |
| Uses | Trebananib (2xCon4C; AMG 386) is an Fc fusion peptibody that prevents Tie2 receptor activation through binding of both angiopoietin 1 (Ang1) and Ang2. Trebananib has anti-angiogenesis activity[1][2]. | | References | [1] Trebananib
[2] Moore KN, et al. A phase II trial of trebananib (AMG 386; IND#111071), a selective angiopoietin 1/2 neutralizing peptibody, in patients with persistent/recurrent carcinoma of the endometrium: An NRG/Gynecologic Oncology Group trial. Gynecol Oncol. 2015 Sep;138(3):513-8. DOI:10.1016/j.ygyno.2015.07.006 |
| | AMG-386,Trebananib Preparation Products And Raw materials |
|